Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers

Despite the substantial changes resulting from the introduction of combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) remains substantial. Blood–brain barrier impairment (BBBi) is a frequent feature in people living with HIV (PLWH) and it may persist despite effective antiretroviral treatment. A cross-sectional study was performed in PLWH who underwent lumbar puncture for clinical reasons or research protocols and several cerebrospinal fluid biomarkers were studied. BBBi was defined as cerebrospinal fluid-to-serum albumin ratio (CSAR) >6.5 (<40 years) or >8 (>40 years). We included 464 participants: 147 cART-naïve and 317 on cART. Male sex was prevalent in both groups (72.1% and 72.2% respectively); median age was 44 (38–52) years in naïve and 49 (43–57) years in treated subjects. BBBi was observed in 35.4% naïve and in 22.7% treated participants; the use of integrase inhibitors was associated with a lower prevalence (18.3 vs. 30.9%, p = 0.050). At multivariate binary logistic regression (including age and sex) nadir CD4 cell count (p = 0.034), presence of central nervous system (CNS) opportunistic infections (p = 0.024) and cerebrospinal fluid (CSF) HIV RNA (p = 0.002) in naïve participants and male sex (p = 0.021), a history of CNS opportunistic infections (p = 0.001) and CSF HIV RNA (p = 0.034) in treated patients were independently associated with BBBi. CSF cells and neopterin were significantly higher in participants with BBBi. BBBi was prevalent in naïve and treated PLWH and it was associated with CSF HIV RNA and neopterin. Systemic control of viral replication seems to be essential for BBB integrity while sex and treatment influence need further studies

Is radical innovation in architecture crucial to sustainability? Lessons from three Scottish contemporary buildings

Radical innovation is largely recognised as a medium for advancement, a source of growth for economies, and a trigger for progress in different economic sectors. Often, this type of innovation is identified with technological advancements, disruptive phenomena and the creation of new systems and dynamics. Yet, within the context of a changing world, in which principles of economic, environmental and social sustainability are largely adopted as common objectives, a reflection on the type of progress and the need for radical innovation is necessary with the aim of informing on their impacts and effectiveness. This work presents an analysis of a number of contemporary Scottish architectural designs, developed under the aegis of sustainability principles, and explores the types of sustainable innovations introduced and the results achieved by analyzing the type of design change that triggered specific sustainable results, demonstrating alternative innovation strategies, other than the radical one. This analysis provides a basis for discussion on the need for radical innovation in the context of sustainable architecture and explores the role of other types of innovation against the results achieved. This discussion could contribute to a better understanding of the current state of practice in architectural design, as well as in policy making in regard to the design and management of the future built environment

A Region of Violent Star Formation in the Irr Galaxy IC 10: Structure and Kinematics of Ionized and Neutral Gas

We have used observations of the galaxy IC 10 at the 6-m telescope of the Special Astrophysical Observatory with the SCORPIO focal reducer in the Fabry-Perot interferometer mode and with the MPFS spectrograph to study the structure and kinematics of ionized gas in the central region of current intense star formation. Archive VLA 21-cm observations are used to analyze the structure and kinematics of neutral gas in this region. High-velocity wings of the H-alpha and [SII] emission lines were revealed in the inner cavity of the nebula HL 111 and in other parts of the complex of violent star formation. We have discovered local expanding neutral-gas shells around the nebulae HL 111 and HL 106.Comment: 22 pages, 10 figures; accepted in Astronomy Report

Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Coffee consumption is believed to have chemopreventive and chemotherapeutic effects and to contribute to preventing thedevelopment and progression of cancer. However, there is still controversy around these claims. As indicated in our previousworks, diet can influence the risk of breast cancer. Intake of coffee is hypothesized to reduce this risk, but current scientificevidence is not conclusive. This work is aimed at studying the effects of Robusta coffee bean extract on cell viability,proliferation, and apoptosis of different human cancers, especially breast cancer cell lines. To this end, cell viability wasevaluated by Alamar Blue in 2D and 3D models, the cell cycle by PI, apoptosis by annexin V, mitochondrial morphology, andfunctionality by mitoTracker, and colony formation capacity by the clonogenic assay. Green and dark coffee extract significantlyreduced viability in human breast, colorectal, brain, and bone cancer cells. Coffee anticancer activity was clearly evidenced inMDA-MB-231 (ER-) and MCF-7 (ER+) breast cancer cells but not in the normal breast cell line. In addition, coffee extractinduces an increase S phase and a decrease G2/M population in breast cancer cells, affected the mitochondrial morphology, andtriggered apoptosis. MDA-MB-231 breast cancer cells lost their clonogenic capacity after treatment. The antitumor activity wasdemonstrated in both 2D and 3D culture cell modelsResearch Article

Discovery of a Be/X-ray pulsar binary and associated supernova remnant in the Wing of the SMC

We report on a new Be/X-ray pulsar binary located in the Wing of the Small Magellanic Cloud (SMC). The strong pulsed X-ray source was discovered with the Chandra and XMM-Newton X-ray observatories. The X-ray pulse period of 1062 s is consistently determined from both Chandra and XMM-Newton observations, revealing one of the slowest rotating X-ray pulsars known in the SMC. The optical counterpart of the X-ray source is the emission-line star 2dFS 3831. Its B0-0.5(III)e+ spectral type is determined from VLT-FLAMES and 2dF optical spectroscopy, establishing the system as a Be/X-ray binary (Be-XRB). The hard X-ray spectrum is well fitted by a power-law with additional thermal and blackbody components, the latter reminiscent of persistent Be-XRBs. This system is the first evidence of a recent supernova in the low density surroundings of NGC 602. We detect a shell nebula around 2dFS 3831 in H-alpha and [O III] images and conclude that it is most likely a supernova remnant. If it is linked to the supernova explosion that created this new X-ray pulsar, its kinematic age of (2-4)x10^4 yr provides a constraint on the age of the pulsar.Comment: 5 pages, 5 figures, accepted for publication in MNRAS Letter

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks